CJC-1295 DAC

Prolong Growth Hormone Signaling with Extended Activity

CJC-1295 DAC (Drug Affinity Complex) is a synthetic peptide designed to stimulate growth hormone (GH) release by acting on the pituitary gland. Unlike shorter-acting secretagogues, the DAC modification allows CJC-1295 to bind to albumin in the bloodstream, significantly extending its biological half-life.

This extended activity results in sustained GH and IGF-1 elevation over several days, positioning CJC-1295 DAC as a compound of interest in research focused on muscle growth, recovery, metabolic efficiency, and age-related decline.

Product features

• Drug Affinity Complex (DAC) technology — extends biological half-life up to 6–8 days.
• Long-acting GH secretagogue — supports sustained GH and IGF-1 signaling.
• Lyophilized (freeze-dried) formulation — enhances stability and shelf life.
• Sterile 3 mL glass vial — packaged to maintain compound integrity.
• Butyl rubber stopper — designed for secure resealability.
• Pyrogen-free & tamper-evident flip cap — ensures research-grade quality control.

Key benefits (Research Highlights)

• Sustained GH & IGF-1 release — DAC binding enables prolonged hormonal elevation compared to non-modified peptides.
• Muscle growth & recovery pathways — GH pulsatility is associated with protein synthesis, lean muscle development, and enhanced recovery.
• Fat loss & metabolic support — studied for increasing metabolic rate and promoting lipolysis during recomposition-focused research.
• Anti-aging & regenerative interest — elevated GH and IGF-1 levels are linked to joint repair, skin elasticity, sleep quality, and vitality.
• Sleep & cognitive benefits — enhanced GH pulses during deep sleep may support memory consolidation and mood stability.
• Synergistic research applications — frequently studied alongside GHRPs such as Ipamorelin or GHRP-2 for amplified GH response.

Research reference: dosage ranges used in studies

Scientific literature evaluating CJC-1295 DAC has explored varying quantities and dosing intervals due to its extended half-life. Research protocols typically focus on sustained GH elevation rather than frequent administration.

These referenced quantities reflect controlled research protocols only and are provided strictly for informational and educational context. They are not intended to represent instructions, recommendations, or guidance for personal use.

Research reference: safety & tolerability observations

In controlled research environments, CJC-1295 DAC has generally been described as well-tolerated. Observed physiological responses vary depending on study duration, hormonal status, and combination protocols.

• Transient GH and IGF-1 elevation noted in endocrine-focused studies
• Temporary fluid balance or metabolic adjustments observed in some models
• Overall favorable tolerability reported across performance and aging research settings

These observations are derived from published research and are presented solely to support transparency within a research context. They should not be interpreted as medical advice or predictive outcomes.

Not sure if this compound aligns with your goals? Our consultation service is available to help you determine whether CJC-1295 DAC fits your muscle growth, recovery, or performance-focused research objectives.

Disclaimer: For research purposes only. Information provided is for educational reference and is not intended as medical advice.